More research needed to investigate the impact of pesticides on brain cells in Parkinson’s
Most recognisable from Sky Sports' live darts coverage, Dave Clark was diagnosed with Parkinson's in 2011 and has been an incredible support to Parkinson's UK over the years.
Take a look at how the bright and brilliant Parkinson’s community marked World Parkinson’s Day 2023.
Parkinson's UK and the Walking Football Association (WFA) are helping more people with Parkinson's to start their physical activity journey.
On 19 April, the All-Party Parliamentary Group (APPG) on Parkinson’s and the APPG on Diabetes held a joint meeting to discuss the role of mental health symptoms and treatment in these two long-term conditions and how care can be improved in England.
This year’s cost of living payments will be sent out from this week. But, with 2 in 3 of the Parkinson’s community struggling to cover living costs, they are nowhere near enough.
People must now bring photo ID to polling stations to be eligible to vote. We explore what this means for the Parkinson’s community.
Presenter and commercial model Linda E is supporting Parkinson’s UK to raise awareness of the condition.
Latest study results show a new test could help diagnose Parkinson’s before damage occurs to brain cells.
We've teamed up with the Scottish Ambulance Service as part of a drive to get medication on time to people with Parkinson’s.
Northern Irish broadcaster and journalist, Claire McCollum, has joined as an ambassador for Parkinson’s UK.
David "Kid" Jensen returns for a third series on Jazz FM with an extended 8 week run starting Saturday 8 April.
Parkinson’s UK has been recognised for providing reliable, accurate and trustworthy health information.
Results from a study of a technique known as focused ultrasound have shown a benefit for people with Parkinson’s with movement problems, for up to a year after treatment.
We've launched a new guide to help more people living with Parkinson's to enjoy a healthy and active lifestyle.
From 1 April, we're introducing the new role of Director of the Parkinson’s Virtual Biotech alongside the existing role of Director of Research.
A survey of over 4,000 people with long-term conditions, including those with Parkinson’s, on prescription charges, has found the charge is a barrier to accessing medicine.
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.